Gastroenterology

General Hepatology

More in General Hepatology

Gene Therapy Promising for Rare Jaundice Syndrome

Early-phase data suggest a dose that can keep bilirubin in check without hours of phototherapy

Aug 16, 2023
A close up of a woman’s eye yellowed by jaundice.
FDA OKs First Liver-Directed Treatment for Metastatic Uveal Melanoma

Hepzato Kit melphalan delivery system produced objective responses in 36% of patients

Aug 15, 2023
FDA APPROVED melphalan/Hepatic Delivery System (Hepzato Kit) over a CT scan of liver metastasis
Pollution and Antibiotic Resistance; Troponin and Mortality

Also in TTHealthWatch: statins for cardioprotection in cancer patients on chemotherapy

Aug 12, 2023
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Sugary Drinks Tied to Higher Liver Cancer Risk in Women

Intake of sugar-sweetened beverages also linked with higher incidence of liver disease mortality

Aug 08, 2023
A photo of a mature woman outdoors drinking a pink beverage in a clear plastic cup.
Aspartame Is a 'Possible' Carcinogen, WHO Declares

But the organization's recommended limits on aspartame consumption remain unchanged

Jul 13, 2023
A photo of a spoonful of aspartame-based sweetener in front of the container it came from.
NAFLD and T2DM Bodes Higher Risk of Liver Decompensation, Cancer

Several-fold higher risks compared with NAFLD patients without diabetes

Jul 11, 2023
A close up photo of a man testing his blood sugar with a glucose meter.
NAFLD Gets a New Name. Will This One Stick?

New name ditches "nonalcoholic" and "fatty," clarifies etiology

Jun 30, 2023
A computer rendering of a nonalcoholic liver disease.
'Jarringly' Low Hep C Cure Rates a Decade After New Treatments, CDC Says

Lack of rapid testing and payer restrictions are creating barriers, experts say

Jun 29, 2023
A computer rendering of a hepatitis C virus in the bloodstream.
Novel Triple Agonist Nabs Biggest Weight Loss Yet in Obesity Trial

Plus, two other studies on retatrutide show benefit in type 2 diabetes, fatty liver disease

Jun 26, 2023
ADA over a photo of the San Diego Convention Center in San Diego, CA.
Can AI Help Determine If Liver Cancer Will Respond to Standard Treatment?

Early model suggests a way to predict progression-free survival

Jun 26, 2023
EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria
Fecal Matter Transplant Shows Promise in Cirrhosis

Pilot trial demonstrates that FMT can boost gut health, prevent serious infections

Jun 25, 2023
EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria
'Game Changer' in NASH: Resmetirom Hits Endpoints in Pivotal Study

Investigational drug more likely to resolve severe form of fatty liver disease, improve fibrosis

Jun 22, 2023
EASL over a photo of Messe Wien Exhibition Congress Center, Wien, Austria
Ocaliva for NASH Gets Thumbs Down From FDA Advisors

Difficulty of risk mitigation for potential drug-induced liver injury weighed heavily on members

May 19, 2023
FDA ADCOMM obeticholic acid (Ocaliva) over a computer rendering of a liver with fibrosis.
NASH Drug Candidate Comes With 'Serious Risks,' Says FDA Staff

Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug

May 17, 2023
FDA ADCOMM obeticholic acid (Ocaliva) over a computer rendering of a liver with fibrosis.
More in General Hepatology

Continuing Medical Education